In a 5‑month‑old male infant with a diffuse rash since birth, thin sparse eyebrows and sparse hair, what is the likely diagnosis and recommended initial management?

Netherton Syndrome

This clinical presentation—diffuse rash since birth, sparse hair, and thin/sparse eyebrows in a 5-month-old male—is highly suggestive of Netherton syndrome, a severe congenital ichthyosis that requires immediate multidisciplinary evaluation and aggressive supportive management to prevent life-threatening complications.

Why Netherton Syndrome is the Leading Diagnosis

The triad of findings points directly to this diagnosis:

• Congenital erythroderma/ichthyosis (rash since neonatal life affecting entire body)
• Hair abnormalities (sparse scalp hair and thin, sparse eyebrows—characteristic of trichorrhexis invaginata or "bamboo hair")
• Presentation in early infancy in a male infant

Netherton syndrome is specifically highlighted in the most recent international guidelines 1 as requiring special management considerations due to its severity and unique complications. This autosomal recessive condition results from mutations in the SPINK5 gene, causing severe skin barrier dysfunction.

Immediate Diagnostic Steps

Confirm the diagnosis through:

• Microscopic hair examination looking for trichorrhexis invaginata (bamboo hair)—pathognomonic for Netherton syndrome
• Skin biopsy if hair findings are inconclusive
• Genetic testing for SPINK5 mutations for definitive confirmation

Assess for complications immediately:

• Growth parameters and nutritional status (failure to thrive is common)
• Signs of dehydration or electrolyte imbalance
• Temperature instability (hyperthermia or hypothermia)
• Evidence of cutaneous infections
• Elevated IgE levels and atopic manifestations

Critical Initial Management Priorities

Skin Barrier Support

• Intensive emollient therapy multiple times daily to reduce transepidermal water loss
• Maintain thermoneutral environment to prevent temperature dysregulation
• Monitor for and aggressively treat skin infections (increased susceptibility due to barrier defect)

Nutritional Support

• High-calorie diet to compensate for increased metabolic demands from chronic inflammation and barrier dysfunction 1
• Monitor growth closely—failure to thrive is a major comorbidity
• Consider nutritional supplementation if growth falters

Infection Prevention

• Low threshold for antibiotic treatment when infection is suspected
• Vaccination schedule should proceed as normal despite the condition 1
• Monitor for both bacterial and viral skin infections

Systemic Complications Monitoring

• Ophthalmologic evaluation for ectropion and corneal complications
• Assess for atopic manifestations (asthma, food allergies, elevated IgE)
• Monitor for enteropathy and malabsorption

Common Pitfalls to Avoid

Do not dismiss this as simple atopic dermatitis or seborrheic dermatitis. The combination of congenital onset, hair abnormalities, and diffuse involvement distinguishes Netherton syndrome from more benign conditions 2.

Do not delay referral to dermatology. Netherton syndrome requires specialized care and can be life-threatening in infancy due to severe barrier dysfunction, leading to dehydration, electrolyte imbalances, hypernatremic dehydration, and sepsis 1.

Do not overlook the hair examination. The characteristic bamboo hair may not be present on all hair shafts, so multiple hairs should be examined microscopically 2.

Differential Considerations

While Netherton syndrome is most likely, briefly consider:

• Other congenital ichthyoses (but hair findings make Netherton most probable) 1
• Hypohidrotic ectodermal dysplasia (presents with sparse hair and rash, but typically with fever due to inability to sweat, frontal bossing, and characteristic facies) 3
• Ectodermal dysplasia-skin fragility syndrome (includes sparse hair but characterized by skin fragility, erosions, and palmoplantar keratoderma) 4

The absence of fever episodes, characteristic facies, or prominent skin fragility/erosions makes these alternatives less likely.

Long-term Outlook

Quality of life and morbidity depend on aggressive early management. The neonatal period is particularly high-risk for mortality due to complications 1. With appropriate supportive care, many patients survive infancy, though they face ongoing challenges with atopy, infections, and growth. Recent therapeutic advances including consideration of biologic therapies for severe cases are evolving 1.